Best, Scott
Lam, Vi
Liu, Tingting
Bruss, Nur
Kittai, Adam
Danilova, Olga V.
Murray, Susan
Berger, Allison
Pennock, Nathan D.
Lind, Evan F. http://orcid.org/0000-0001-7026-2012
Danilov, Alexey V. http://orcid.org/0000-0003-4461-0970
Funding for this research was provided by:
Leukemia and Lymphoma Society (6542-18, 2319-19)
Leukemia and Lymphoma Society
Article History
Received: 9 October 2019
Revised: 25 February 2020
Accepted: 3 March 2020
First Online: 16 March 2020
Compliance with ethical standards
:
: AVD has received research funding from Astra Zeneca, Gilead Sciences, Genentech, Aptose Biosciences, MEI Pharma, Takeda Oncology, Bayer Oncology, Verastem Oncology, and Bristol-Meyers-Squibb; honoraria from Astra Zeneca, Celgene, Curis, Genentech, Gilead Sciences, Janssen Oncology, Pharmacyclics, Seattle Genetics, TG Therapeutics, and Verastem Oncology. EFL has received research funding from Celgene, Amgen, Janssen Pharmaceuticals, Monojul, and Kyn Therapeutics. AB is employed by Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.